Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Design Therapeutics
DSGN
$938M
| $37.1K | ﹤0.01% |
11,083
-665
| -6% | -$2.59K |
|
2552
Dragonfly Energy
DFLI
$18M
| $36.8K | ﹤0.01% |
+483
| New | +$37.4K |
|
|
MRNS
2553
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $36.7K | ﹤0.01% |
31,333
+12,934
| +70% | +$32.4K |
|
|
LUNA
2554
DELISTED
Luna Innovations Incorporated
LUNA
| $36.6K | ﹤0.01% |
+11,439
| New | +$33.9K |
|
|
IMA
2555
ImageneBio Inc
IMA
$62.5M
| $36.1K | ﹤0.01% |
+1,822
| New | +$32.2K |
|
2556
BARK
BARK
$91.5M
| $33.6K | ﹤0.01% |
+928
| New | +$23.8K |
|
2557
Butterfly Network
BFLY
$2.54B
| $32.8K | ﹤0.01% |
38,988
-39,233
| -50% | -$36.6K |
|
2558
FuelCell Energy
FCEL
$1.56B
| $32.5K | ﹤0.01% |
1,698
+874
| +106% | +$23.4K |
|
2559
Entravision Communication
EVC
$745M
| $30.2K | ﹤0.01% |
14,886
-61,532
| -81% | -$127K |
|
2560
Caribou Biosciences
CRBU
$178M
| $30.1K | ﹤0.01% |
+18,341
| New | +$58.6K |
|
2561
Seer Inc
SEER
$112M
| $29.9K | ﹤0.01% |
+17,785
| New | +$33.2K |
|
2562
Accuray
ARAY
$33.6M
| $29.7K | ﹤0.01% |
+16,322
| New | +$31.1K |
|
2563
Fossil Group
FOSL
$332M
| $28.4K | ﹤0.01% |
+19,703
| New | +$22.4K |
|
2564
5E Advanced Materials
FEAM
$69.3M
| $26.9K | ﹤0.01% |
+967
| New | +$30.3K |
|
2565
Opendoor
OPEN
$3.43B
| $26.1K | ﹤0.01% |
14,668
-40,140
| -73% | -$86.6K |
|
|
NOTE
2566
DELISTED
FiscalNote
NOTE
| $25.8K | ﹤0.01% |
+1,475
| New | +$23.4K |
|
|
MOND
2567
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $24.2K | ﹤0.01% |
+10,082
| New | +$22.5K |
|
2568
Kaltura
KLTR
$246M
| $24K | ﹤0.01% |
+19,962
| New | +$24.1K |
|
2569
Noodles & Co
NDLS
$89.7M
| $23.3K | ﹤0.01% |
+1,840
| New | +$26.2K |
|
|
LAZR
2570
DELISTED
Luminar Technologies
LAZR
| $23.2K | ﹤0.01% |
+1,040
| New | +$24.6K |
|
|
NB
2571
NioCorp Developments
NB
$676M
| $22.6K | ﹤0.01% |
+13,046
| New | +$30.4K |
|
2572
System1
SST
$16.8M
| $22.5K | ﹤0.01% |
+1,484
| New | +$25K |
|
2573
BioXcel Therapeutics
BTAI
$25.2M
| $18.4K | ﹤0.01% |
+898
| New | +$30.1K |
|
|
PRST
2574
DELISTED
Presto Technologies, Inc. Common Stock
PRST
| $16.9K | ﹤0.01% |
+241,538
| New | +$35.2K |
|
|
FRGE
2575
DELISTED
Forge Global Holdings
FRGE
| $16.5K | ﹤0.01% |
755
-2,479
| -77% | -$65.9K |
|
Similar funds
Cliff Asness's Q2 2024 Portfolio in Review
As of Q2 2024, Cliff Asness held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cliff Asness deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- Cliff Asness's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- Cliff Asness added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- Cliff Asness's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- Cliff Asness fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- Cliff Asness's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- Cliff Asness opened 313 new positions and closed 123 in Q2 2024.
- Cliff Asness's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.